Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by THOMAS A ALOIA and CLAUDIUS CONRAD.
THOMAS A ALOIA
Connection Strength
4.858
CLAUDIUS CONRAD
  1. Loss of muscle mass during preoperative chemotherapy as a prognosticator for poor survival in patients with colorectal liver metastases. Surgery. 2019 02; 165(2):329-336.
    View in: PubMed
    Score: 0.161
  2. Remnant Liver Ischemia as a Prognostic Factor for Cancer-Specific Survival After Resection of Colorectal Liver Metastases. JAMA Surg. 2017 Oct 18; 152(10):e172986.
    View in: PubMed
    Score: 0.152
  3. Reduction of Cardiopulmonary/Renal Complications with Serum BNP-Guided Volume Status Management in Posthepatectomy Patients. J Gastrointest Surg. 2018 03; 22(3):467-476.
    View in: PubMed
    Score: 0.152
  4. Individualized Treatment Sequencing Selection Contributes to Optimized Survival in Patients with Rectal Cancer and Synchronous Liver Metastases. Ann Surg Oncol. 2017 Dec; 24(13):3857-3864.
    View in: PubMed
    Score: 0.151
  5. Operative and short-term oncologic outcomes of laparoscopic versus open liver resection for colorectal liver metastases located in the posterosuperior liver: a propensity score matching analysis. Surg Endosc. 2018 04; 32(4):1776-1786.
    View in: PubMed
    Score: 0.151
  6. Inflammation and pro-resolution inflammation after hepatobiliary surgery. World J Surg Oncol. 2017 Aug 10; 15(1):152.
    View in: PubMed
    Score: 0.150
  7. Extended Lymphadenectomy Is Required for Incidental Gallbladder Cancer Independent of Cystic Duct Lymph Node Status. J Gastrointest Surg. 2018 01; 22(1):43-51.
    View in: PubMed
    Score: 0.149
  8. Total Laparoscopic Management for Stage IV Colorectal Cancer Requiring Multivisceral Resection. Ann Surg Oncol. 2017 Sep; 24(9):2595.
    View in: PubMed
    Score: 0.147
  9. Incidental Gallbladder Cancer: Residual Cancer Discovered at Oncologic Extended Resection Determines Outcome: A Report from High- and Low-Incidence Countries. Ann Surg Oncol. 2017 Aug; 24(8):2334-2343.
    View in: PubMed
    Score: 0.147
  10. Comparative effectiveness of first-line radiofrequency ablation versus surgical resection and transplantation for patients with early hepatocellular carcinoma. Cancer. 2017 05 15; 123(10):1817-1827.
    View in: PubMed
    Score: 0.144
  11. Total Transthoracic Approach Facilitates Laparoscopic Hepatic Resection in Patients with Significant Prior Abdominal Surgery. Ann Surg Oncol. 2017 May; 24(5):1376-1377.
    View in: PubMed
    Score: 0.143
  12. RAS Mutation Is Associated with Decreased Survival in Patients Undergoing Repeat Hepatectomy for Colorectal Liver Metastases. J Gastrointest Surg. 2017 01; 21(1):68-77.
    View in: PubMed
    Score: 0.138
  13. Laparoscopic Insulinoma Enucleation from the Retro-Pancreatic Neck: A Stepwise Approach. Ann Surg Oncol. 2016 06; 23(6):2001.
    View in: PubMed
    Score: 0.136
  14. Transthoracic Port Placement Increases Safety of Total Laparoscopic Posterior Sectionectomy. Ann Surg Oncol. 2016 07; 23(7):2167.
    View in: PubMed
    Score: 0.135
  15. Evaluating the Clinical Applicability of the European Staging System for Perihilar Cholangiocarcinoma. J Gastrointest Surg. 2016 Apr; 20(4):741-7.
    View in: PubMed
    Score: 0.134
  16. Parenchymal-sparing Hepatectomy in Colorectal Liver Metastasis Improves Salvageability and Survival. Ann Surg. 2016 Jan; 263(1):146-52.
    View in: PubMed
    Score: 0.134
  17. After Pancreatectomy, the ?90 Days from Surgery? Definition Is Superior to the ?30 Days from Discharge? Definition for Capture of Clinically Relevant Readmissions. J Gastrointest Surg. 2016 Jan; 20(1):77-84; discussion 84.
    View in: PubMed
    Score: 0.134
  18. Spleen and splenic vessel preserving distal pancreatectomy for bifocal PNET in a young patient with MEN1. Surg Endosc. 2016 10; 30(10):4619.
    View in: PubMed
    Score: 0.134
  19. Musical preference correlates closely to professional roles and specialties in operating room: A multicenter cross-sectional cohort study with 672 participants. Surgery. 2016 May; 159(5):1260-8.
    View in: PubMed
    Score: 0.134
  20. Advances in hepatectomy technique: Toward zero transfusions in the modern era of liver surgery. Surgery. 2016 Mar; 159(3):793-801.
    View in: PubMed
    Score: 0.133
  21. Patient-Reported Outcomes Accurately Measure the Value of an Enhanced Recovery Program in Liver Surgery. J Am Coll Surg. 2015 Dec; 221(6):1023-30.e1-2.
    View in: PubMed
    Score: 0.132
  22. Evaluating surgeon attitudes towards the safety and efficacy of portal vein occlusion and associating liver partition and portal vein ligation: a report of the MALINSA survey. HPB (Oxford). 2015 Oct; 17(10):936-41.
    View in: PubMed
    Score: 0.130
  23. Techniques of intragastric laparoscopic surgery. Surg Endosc. 2015 Jan; 29(1):202-6.
    View in: PubMed
    Score: 0.122
  24. Laparoscopic intragastric surgery for early gastric cancer and gastrointestinal stromal tumors. Ann Surg Oncol. 2014 Aug; 21(8):2620.
    View in: PubMed
    Score: 0.121
  25. Return to intended oncologic treatment (RIOT): a novel metric for evaluating the quality of oncosurgical therapy for malignancy. J Surg Oncol. 2014 Aug; 110(2):107-14.
    View in: PubMed
    Score: 0.120
  26. APC and PIK3CA Mutational Cooperativity Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colorectal Liver Metastases. Ann Surg. 2020 12; 272(6):1080-1085.
    View in: PubMed
    Score: 0.047
  27. Comprehensive Complication Index Validates Improved Outcomes Over Time Despite Increased Complexity in 3707 Consecutive Hepatectomies. Ann Surg. 2020 04; 271(4):724-731.
    View in: PubMed
    Score: 0.045
  28. Deleterious Effect of RAS and Evolutionary High-risk TP53 Double Mutation in Colorectal Liver Metastases. Ann Surg. 2019 05; 269(5):917-923.
    View in: PubMed
    Score: 0.042
  29. RAS Mutation Clinical Risk Score to Predict Survival After Resection of Colorectal Liver Metastases. Ann Surg. 2019 01; 269(1):120-126.
    View in: PubMed
    Score: 0.041
  30. Validation of American Joint Committee on Cancer eighth staging system for gallbladder cancer and its lymphadenectomy guidelines. J Surg Res. 2018 10; 230:148-154.
    View in: PubMed
    Score: 0.040
  31. Preoperative Fluorouracil, Doxorubicin, and Streptozocin for the Treatment of Pancreatic Neuroendocrine Liver Metastases. Ann Surg Oncol. 2018 Jun; 25(6):1709-1715.
    View in: PubMed
    Score: 0.039
  32. Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series. Lancet Gastroenterol Hepatol. 2018 05; 3(5):337-348.
    View in: PubMed
    Score: 0.039
  33. SMAD4 gene mutation predicts poor prognosis in patients undergoing resection for colorectal liver metastases. Eur J Surg Oncol. 2018 05; 44(5):684-692.
    View in: PubMed
    Score: 0.039
  34. Embryonic Origin of Primary Colon Cancer Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colon Cancer Liver Metastases. Ann Surg. 2018 03; 267(3):514-520.
    View in: PubMed
    Score: 0.039
  35. Two-Stage Hepatectomy vs One-Stage Major Hepatectomy with Contralateral Resection or Ablation for Advanced Bilobar Colorectal Liver Metastases. J Am Coll Surg. 2018 05; 226(5):825-834.
    View in: PubMed
    Score: 0.039
  36. Impact of Prior Hepatectomy History on Local Tumor Progression after Percutaneous Ablation of Colorectal Liver Metastases. J Vasc Interv Radiol. 2018 03; 29(3):395-403.e1.
    View in: PubMed
    Score: 0.039
  37. Comprehensive Complication Index Predicts Cancer-specific Survival After Resection of Colorectal Metastases Independent of RAS Mutational Status. Ann Surg. 2017 12; 266(6):1045-1054.
    View in: PubMed
    Score: 0.038
  38. Liver resection is justified for patients with bilateral multiple colorectal liver metastases: A propensity-score-matched analysis. Eur J Surg Oncol. 2018 01; 44(1):122-129.
    View in: PubMed
    Score: 0.038
  39. Impact of RAS Mutations in Metastatic Colorectal Cancer After Potentially Curative Resection: Does Site of Metastases Matter? Ann Surg Oncol. 2018 Jan; 25(1):179-187.
    View in: PubMed
    Score: 0.038
  40. Long term outcome after resection of liver metastases from squamous cell carcinoma. Eur J Surg Oncol. 2017 Nov; 43(11):2129-2134.
    View in: PubMed
    Score: 0.038
  41. Natural History of T1N0M0 Hepatocellular Carcinoma: Large-Scale Study in the United States. Oncology. 2017; 93(4):233-242.
    View in: PubMed
    Score: 0.037
  42. Neutrophil-to-lymphocyte ratio predicts prognosis after neoadjuvant chemotherapy and resection of intrahepatic cholangiocarcinoma. Surgery. 2017 10; 162(4):752-765.
    View in: PubMed
    Score: 0.037
  43. Definitive radiation therapy for hepatocellular carcinoma with portal vein tumor thrombus. Clin Transl Radiat Oncol. 2017 Jun; 4:39-45.
    View in: PubMed
    Score: 0.037
  44. Portal Vein Embolization Reduces Postoperative Hepatic Insufficiency Associated with Postchemotherapy Hepatic Atrophy. J Gastrointest Surg. 2018 01; 22(1):60-67.
    View in: PubMed
    Score: 0.037
  45. Hepatic atrophy following preoperative chemotherapy predicts hepatic insufficiency after resection of colorectal liver metastases. J Hepatol. 2017 07; 67(1):56-64.
    View in: PubMed
    Score: 0.036
  46. Local therapy reduces the risk of liver failure and improves survival in patients with intrahepatic cholangiocarcinoma: A comprehensive analysis of 362 consecutive patients. Cancer. 2017 04 15; 123(8):1354-1362.
    View in: PubMed
    Score: 0.036
  47. Is hepatectomy justified for patients with RAS mutant colorectal liver metastases? An analysis of 524 patients undergoing curative liver resection. Surgery. 2017 02; 161(2):332-340.
    View in: PubMed
    Score: 0.035
  48. Prognosis of Fibrolamellar Carcinoma Compared to Non-cirrhotic Conventional Hepatocellular Carcinoma. J Gastrointest Surg. 2016 10; 20(10):1725-31.
    View in: PubMed
    Score: 0.035
  49. A Nomogram to Predict Hypertrophy of Liver Segments 2 and 3 After Right Portal Vein Embolization. J Gastrointest Surg. 2016 07; 20(7):1317-23.
    View in: PubMed
    Score: 0.034
  50. RAS Mutation Predicts Positive Resection Margins and Narrower Resection Margins in Patients Undergoing Resection of Colorectal Liver Metastases. Ann Surg Oncol. 2016 08; 23(8):2635-43.
    View in: PubMed
    Score: 0.034
  51. Use of Prophylactic Antibiotics to Prevent Abscess Formation Following Hepatic Ablation in Patients with Prior Enterobiliary Manipulation. J Gastrointest Surg. 2016 08; 20(8):1428-34.
    View in: PubMed
    Score: 0.034
  52. Eradication of Missing Liver Metastases After Fiducial Placement. J Gastrointest Surg. 2016 06; 20(6):1173-8.
    View in: PubMed
    Score: 0.034
  53. Predictors of Safety and Efficacy of 2-Stage Hepatectomy for Bilateral Colorectal Liver Metastases. J Am Coll Surg. 2016 07; 223(1):99-108.
    View in: PubMed
    Score: 0.034
  54. Ninety-day Postoperative Mortality Is a Legitimate Measure of Hepatopancreatobiliary Surgical Quality. Ann Surg. 2015 Dec; 262(6):1071-8.
    View in: PubMed
    Score: 0.033
  55. Meta-analysis of KRAS mutations and survival after resection of colorectal liver metastases. Br J Surg. 2015 Sep; 102(10):1175-83.
    View in: PubMed
    Score: 0.032
  56. Survival After Resection of Gastrointestinal Stromal Tumor and Sarcoma Liver Metastases in 146 Patients. J Gastrointest Surg. 2015 Aug; 19(8):1476-83.
    View in: PubMed
    Score: 0.032
  57. Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study. Ann Surg. 2015 Apr; 261(4):733-9.
    View in: PubMed
    Score: 0.032
  58. Definition of Readmission in 3,041 Patients Undergoing Hepatectomy. J Am Coll Surg. 2015 Jul; 221(1):38-46.
    View in: PubMed
    Score: 0.032
  59. Active Surveillance for Adverse Events Within 90 Days: The Standard for Reporting Surgical Outcomes After Pancreatectomy. Ann Surg Oncol. 2015 Oct; 22(11):3522-9.
    View in: PubMed
    Score: 0.032
  60. Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer. Ann Surg Oncol. 2015 Jul; 22(7):2416-23.
    View in: PubMed
    Score: 0.031
  61. Is complete liver resection without resection of synchronous lung metastases justified? Ann Surg Oncol. 2015 May; 22(5):1585-92.
    View in: PubMed
    Score: 0.031
  62. Volume regeneration of segments 2 and 3 after right portal vein embolization in patients undergoing two-stage hepatectomy. J Gastrointest Surg. 2015 Jan; 19(1):133-41; discussion 141.
    View in: PubMed
    Score: 0.030
  63. Development and validation of insulin-like growth factor-1 score to assess hepatic reserve in hepatocellular carcinoma. J Natl Cancer Inst. 2014 May 09; 106(5).
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.